| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 71,295 | 77,644 | 70,701 | 76,480 | | Cost of Revenue | 47,191 | 58,709 | 45,457 | 44,889 | | | Gross Profit | 24,104 | 18,935 | 25,244 | 31,591 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 29,590 | 26,867 | 27,777 | 23,854 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,085 | 3,126 | 3,146 | 3,085 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,571) | (11,058) | (5,679) | 4,652 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 898 | 1,450 | (1,344) | (2,468) | | Earnings Before Interest And Taxes | (7,673) | (9,608) | (7,023) | 2,184 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (7,673) | (9,608) | (7,023) | 2,184 | | Income Tax Expense | 1,534 | (4,071) | (2,248) | 1,564 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,207) | (5,537) | (4,775) | 620 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,207) | (5,537) | (4,775) | 620 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,207) | ($5,537) | ($4,775) | $620 |
|
0.31% Nasdaq 0.00%
Income Statement
